Methoxetamine: A foe or friend?
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 122, 1-7
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation
- the Korean government (MSIT) (NRF-2017M3A9G2077568)
- National Research Foundation of Korea (2017R1D1A1A02018695)
- Ministry of Food and Drug Safety of Korea (14182MFDS979)
This publication has 67 references indexed in Scilit:
- The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA ReceptorPLOS ONE, 2013
- Analysis of anonymous pooled urine from portable urinals in central London confirms the significant use of novel psychoactive substancesQJM: An International Journal of Medicine, 2012
- Methoxetamine: From drug of abuse to rapid-acting antidepressantMedical Hypotheses, 2012
- Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamineHuman Psychopharmacology: Clinical and Experimental, 2012
- Signaling pathways underlying the rapid antidepressant actions of ketamineNeuropharmacology, 2012
- The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorderProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Positive AMPA Receptor Modulation Rapidly Stimulates BDNF Release and Increases Dendritic mRNA TranslationThe Journal of Neuroscience, 2009
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNature Reviews Drug Discovery, 2008
- Evidence for a supraspinal mechanism in the opioid-mediated antinociceptive effect of ketamineBrain Research, 1991